Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Oct 16:13:1272561.
doi: 10.3389/fonc.2023.1272561. eCollection 2023.

The impact of clinical and translational research on the quality of life during the metastatic colorectal cancer patient journey

Affiliations
Review

The impact of clinical and translational research on the quality of life during the metastatic colorectal cancer patient journey

Marta Rodriguez Castells et al. Front Oncol. .

Abstract

The journey of metastatic colorectal cancer patients is complex and challenging, requiring coordination and collaboration between multiple healthcare providers. Understanding patients' needs, fears, feelings, concerns, and behaviors is essential for providing individualized patient-centered care. In recent years, mCRC patients have experienced improvements in clinical outcomes, from 16 months of overall survival to 32 months, thanks to research. However, there is still room for improvement, and integrating clinical and translational research into routine practice can help patients benefit from treatments and techniques that would not be an option. In the Journey of mCRC patients, living well with cancer and quality of life becomes a priority given the outcomes of the disease. Patient reported outcomes (PRO) and Patient Reported Outcome Measures (PROMs) are becoming therefore new estimands in Oncology. Patient advocates represent important figures in this process by prioritizing issues and research questions; evaluating research designs and the performance of the research; the analysis and interpretation of data; and how results are disseminated. Multidisciplinary Tumor Boards and shared decision-making is essential for designing treatment strategies for individual patients. Quality of Life is often prioritized only when it comes to refractory advanced disease and end-of-life care, but it has to be integrated from the beginning, as the emotional impact of diagnosis leads to a vulnerable situation where patients' needs and preferences can be easily overseen. First-line treatment will be chosen among more treatment options than subsequent lines, with longer progression-free survival and a bigger impact on the outcomes. Practicing patient-centered care and optimizing first-line treatment for colorectal cancer patients requires a comprehensive understanding of patient experience and treatment outcomes, which can guide clinical practice and inform regulatory decisions for the benefit of patients.

Keywords: colorectal cancer; patient journey; patient reported outcome measures; patient reported outcomes; quality of life.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Factors that influence the patient’s quality of life.
Figure 2
Figure 2
Number of publications for the search of the term “Patient Reported Outcome” in PubMed database.

Similar articles

Cited by

References

    1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. . Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin (2021) 71(3):209–49. doi: 10.3322/caac.21660 - DOI - PubMed
    1. Arnold M, Sierra MS, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global patterns and trends in colorectal cancer incidence and mortality. Gut abril (2017) 66(4):683–91. doi: 10.1136/gutjnl-2015-310912 - DOI - PubMed
    1. Maravic Z, Rawicka I, Benedict A, Wyrwicz L, Horvath A, Fotaki V, et al. . A European survey on the insights of patients living with metastatic colorectal cancer: the patient journey before, during and after diagnosis - an Eastern European perspective. ESMO Open (2020) 5(5):e000850. doi: 10.1136/esmoopen-2020-000850 - DOI - PMC - PubMed
    1. Lowes M, Kleiss M, Lueck R, Detken S, Koenig A, Nietert M, et al. . The utilization of multidisciplinary tumor boards (MDT) in clinical routine: results of a health care research study focusing on patients with metastasized colorectal cancer. Int J Colorectal Dis (2017) 32(10):1463–9. doi: 10.1007/s00384-017-2871-z - DOI - PMC - PubMed
    1. Louie BH, Kato S, Kim KH, Lim HJ, Lee S, Okamura R, et al. . Precision medicine-based therapies in advanced colorectal cancer: The University of California San Diego Molecular Tumor Board experience. Mol Oncol (2022) 16(13):2575–84. doi: 10.1002/1878-0261.13202 - DOI - PMC - PubMed

LinkOut - more resources